Moderna (MRNA) skyrocketed today, more than doubling, up 150 percent, on the news of a successful Phase 3 melanoma trial. The combination of Moderna's vaccine with Merck's Keytruda significantly reduced the risk of melanoma returning or spreading...

Qualcomm (QCOM) is being added to the Sound Advice portfolio. A complete explanation will follow in the next issue of Sound Advice scheduled to be published on the first of September, but we are adding QCOM now as a timely investment.

The stock...

We eat our own cooking. The Sound Advice Diversified Growth Fund invests exclusively in the Sound Advice Model Portfolio recommendations. The editor of Sound Advice for 36+ years, Gray Cardiff, manages the Sound Advice Fund and is also an...

A new feature is introduced this month: News and comments relevant to the most recent month are highlighted in bold. Otherwise, context and longer term prospectives will be in regular fonts.

Last month we advised not to get sidetracked by the...